Pulmonary function testing has undergone a quiet but significant evolution over the past several years. This session offers a clear, clinically grounded overview of the major updates from the American Thoracic Society (ATS) and European Respiratory Society (ERS) since 2017.

Attendees will explore how new recommendations are reshaping how we perform, interpret, and apply spirometry, lung volumes, and diffusion capacity in everyday practice.

Presenter: Jose Ramos, Director of IDN & Clinical Trials at Monitored Therapeutics, Inc (MTI)